Using Survival Analysis for Interim Efficacy Assessments in Clinical Trials
Using Survival Analysis for Interim Efficacy Assessments in Clinical Trials Survival Analysis in Interim Efficacy Assessments: Tools for Data-Driven Trial Decisions Interim efficacy assessments are critical checkpoints in clinical trials, especially when evaluating time-to-event outcomes such as survival, progression-free survival (PFS), or disease recurrence. These analyses allow for early decisions—whether to stop a trial for…
Read More “Using Survival Analysis for Interim Efficacy Assessments in Clinical Trials” »